Durvalumab-Induced Hypoparathyroidism

This case reinforces the need for an increased awareness and recognition of durvalumab-induced hypoparathyroidism, in addition to more investigation into its underlying mechanisms and potential management options.

Authors

Institutions

Publication Details

Journal
AACE Endocrinology and Diabetes
Published
2025-05-16
DOI
https://doi.org/10.1016/j.aed.2025.04.005
Citations
1
Primary Topic
Thyroid and Parathyroid Surgery
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Durvalumab-Induced Hypoparathyroidism

Christopher Chan, Varun Manoharan, Manimegalai Manoharan
1 citations
AACE Endocrinology and Diabetes
Thyroid and Parathyroid Surgery
2.01
article

Durvalumab-Induced Hypoparathyroidism

Christopher Chan, Varun Manoharan, Manimegalai Manoharan
article en
1 citations

Abstract

This case reinforces the need for an increased awareness and recognition of durvalumab-induced hypoparathyroidism, in addition to more investigation into its underlying mechanisms and potential management options.

AACE Endocrinology and DiabetesVol. 12(2)
The University of Sydney (AU), Concord Repatriation General Hospital (AU), Liverpool Hospital (AU), Nepean Hospital (AU), UNSW Sydney (AU), Western Sydney University (AU)
Openalex Percentile: Top 16%
Thyroid and Parathyroid Surgery
2.01
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.